GLP-1 considerations for women include interactions with hormonal contraceptives, effects during perimenopause, and special nutritional considerations
She is taking on new patients at our Longmont office and via telehealth
A 2023 study shows that semaglutide, a GLP-1 agonist, reduced cardiovascular events by 20%, while other studies show that the Mediterranean diet can reduce heart disease by up to 30% for those at risk 7,8,9
Injectable medications, while effective, can deter some individuals from beginning or continuing treatment
The Association of Emotional Eating With Overweight/Obesity, Depression, Anxiety/Stress, and Dietary Patterns: A Review of the Current Clinical Evidence
Support post-GLP-1 so you adjust to your new baseline and your results last